Efficacy of buffered and enteric-coated acetylsalicylic acid on platelet aggregation in patients with stable coronary artery disease and type 2 diabetes (CASCADE): rationale and design of a single-center observational comparative study

Efficacy of buffered and enteric-coated acetylsalicylic acid on platelet aggregation in patients with stable coronary artery disease and type 2 diabetes (CASCADE): rationale and design of a single-center observational comparative study

Aim. Enteric-coated acetylsalicylic acid (ASA) is released more slowly and is absorbed in smaller quantities and over a longer period of time, which may lead to bioavailability and antiplatelet effect decrease compared to conventional ASA. Patients with diabetes are characterized by increased platel...

Full description

Saved in:
Bibliographic Details
Main Authors: Zh. D. Kobalava, A. S. Pisaryuk, A. A. Filkova, E. S. Tukhsanboev, A. N. Amirova, A. D. Korneichuk, G. S. Pavlikov, L. R. Burkhanova, I. A. Meray, M. A. Panteleev, A. N. Sveshnikova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2025-02-01
Series:Российский кардиологический журнал
Subjects:
diabetes
stable coronary artery disease
platelet aggregation
acetylsalicylic acid resistance
Online Access:https://russjcardiol.elpub.ru/jour/article/view/6250
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items